I now have comprehensive information from multiple authoritative sources. Let me compile the full answer.
Indications for Calcium Supplements in Pregnancy
1. Prevention of Preeclampsia (Primary Indication)
This is the most evidence-based and widely recognised indication.
WHO Recommendation: Calcium supplementation of 1.5-2 g/day elemental calcium (orally) after 20 weeks' gestation is recommended for women with low dietary calcium intake (< 600 mg/day) to prevent preeclampsia and gestational hypertension. This is not given routinely in high-income countries where dietary calcium is usually adequate.
- Comprehensive Clinical Nephrology, 7th Ed.
American Heart Association / American Stroke Association: Calcium supplementation ≥1 g/day should be considered for women with low dietary intake (<600 mg/day) to prevent preeclampsia. Evidence suggests it approximately halves the risk of preeclampsia.
- Bradley and Daroff's Neurology in Clinical Practice
International Society for the Study of Hypertension in Pregnancy (ISSHP): Recommends calcium 1.2-2.5 g/day when dietary intake is <600 mg/day for women with high-risk features for preeclampsia, including:
- Previous preeclampsia
- Chronic hypertension
- Pre-gestational diabetes mellitus
- Maternal BMI >30 kg/m²
- Antiphospholipid syndrome
- Pregnancy via assisted reproductive technology (ART)
In these high-risk women, calcium is used alongside low-dose aspirin (75-162 mg/day), ideally started before 16-20 weeks.
- Bradley and Daroff's Neurology in Clinical Practice
2. Meeting Increased Calcium Requirements During Pregnancy
During pregnancy, the fetus accretes approximately 25-30 g of calcium by term, with 80% transferred in the third trimester. Maternal intestinal calcium absorption doubles (driven by elevated 1,25(OH)₂D₃), but this adaptation may be insufficient in women with low dietary intake.
Recommended Daily Intake (RDI) for calcium in pregnant women:
- Age 19-50 years: 1000 mg/day
- Age <18 years (adolescents): 1300 mg/day
Less than half of US women meet these dietary calcium recommendations, making supplementation relevant in many patients.
- Creasy & Resnik's Maternal-Fetal Medicine, Principles and Practice
3. Prevention/Management of Pregnancy-Associated Osteoporosis
In women with severe osteoporosis diagnosed during pregnancy or those at high risk (e.g., prolonged corticosteroid use, low BMI, previous fragility fracture), adequate calcium intake of 1200 mg/day of elemental calcium from dietary and supplemental sources is recommended along with vitamin D.
- Creasy & Resnik's Maternal-Fetal Medicine
4. Leg Cramps in Pregnancy
Between 5-30% of pregnant women experience painful leg cramps, particularly in the last trimester. Changes in ionic concentrations of calcium, potassium, magnesium, and sodium may play a role in pathogenesis. Calcium (and magnesium) supplementation is sometimes used, though magnesium lactate has stronger evidence for this symptom.
- Bradley and Daroff's Neurology in Clinical Practice
5. Calcium Gluconate for Magnesium Toxicity
When magnesium sulfate is used for eclampsia seizure prophylaxis, calcium gluconate 1 g IV is the antidote if signs of magnesium toxicity appear (diminished reflexes, respiratory depression).
- Goldman-Cecil Medicine, International Edition
Summary Table
| Indication | Dose | Timing | Evidence Level |
|---|
| Preeclampsia prevention (low Ca intake) | 1.5-2 g/day | After 20 weeks | WHO-recommended |
| Preeclampsia prevention (high-risk women) | 1.2-2.5 g/day | With aspirin, before 16-20 weeks | ISSHP guideline |
| Meeting daily requirements | 1000-1300 mg/day | Throughout pregnancy | Routine |
| Pregnancy-associated osteoporosis | 1200 mg/day total | Throughout | Clinical consensus |
| Leg cramps | Variable | Third trimester | Weak evidence |
| Magnesium toxicity reversal | 1 g IV calcium gluconate | As needed | Established antidote |
Recent Evidence Update
Recent systematic reviews confirm the calcium-preeclampsia benefit but note important nuances:
- A 2024 meta-analysis in BJOG (PMID 38302677) challenges the strength of evidence from prior meta-analyses on calcium for preeclampsia prevention, urging caution in overinterpreting pooled data.
- A 2025 Cochrane review (PMID 41330480) updates evidence on calcium for preventing hypertensive disorders in pregnancy.
- A 2025 systematic review in Medicina (PMID 40731825) provides a broad clinical summary of calcium supplementation in pregnancy.
The core recommendation stands: calcium supplementation is most indicated in women with proven low dietary calcium intake, particularly for preeclampsia prevention, and is not routinely needed in well-nourished populations where dietary intake meets the 1000-1300 mg/day target.